FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4296468339> ?p ?o ?g. }

• W4296468339 endingPage "S398" @default.
• W4296468339 startingPage "S397" @default.
• W4296468339 abstract "Extra-nodal natural killer (NK)/T-cell lymphoma is a rare, distinctive clinicopathologic entity with an aggressive clinical course. High expression of multidrug-resistant (MDR) P-gp on NK lymphoma cells renders this disease resistant to anthracycline-based chemotherapy regimens. Over the years, based on retrospective analysis and phase II studies, regimens with L-asparaginase and non-MDR drugs have been used.To evaluate the outcome of patients with extra-nodal NK/T-cell lymphoma treated in a tertiary cancer care center in India from 2012 to 2021.Retrospective, observational, single-center study.Hematolymphoid Department, Tata Memorial Hospital.From January 2010 to December 2021, all consecutive patients with NK/T-cell lymphoma were analyzed.Relapse-free survival and overall survival.A total of 78 patients with a diagnosis of extra-nodal NK/T-cell lymphoma were treated from 2010 to 2021. Amongst them, 56 (71.8%) were male, with a median age of 40 years (15-71 years). The most common presenting symptom was nasal swelling (9%), followed by dysphagia (3.8%). B symptoms were present in 35 patients (45%). Only 5% had HLH anytime during the treatment. One-third of the patients had an ECOG performance status >1. Nasal type constituted 80% of the cohort, regional node was involved in 60%, distant node was involved in 28%, 33% had more than 1 extra-nodal site involved, 23% had bulky disease, and 40% had advanced stage (stage 3-4) at presentation. EBV LMP1 was positive in 19 patients (24%). EBERISH was available in 9 patients, of which 7 were positive. Fifteen patients received treatment prior to presentation to our center (CHOP in 10 patients). At our center, the SMILE chemotherapy protocol was administered to 52 patients (66.7%). Consolidative radiation therapy was administered in 43 patients (55.1%). The best radiological response of CR was achieved in 49 patients (62.8%). After a median follow-up of 30 months, 30 (38.5%) patients relapsed and 30 (38.5%) died. Median relapse-free survival was 45 (95%CI: 5.1-84.8) months. Overall survival at 36 months was 53.4% (95%CI: 41.7%-68.4%).The outcome of NK/T-cell lymphoma in our cohort is comparable to the outcomes found in the literature." @default.
• W4296468339 created "2022-09-21" @default.
• W4296468339 creator A5001774710 @default.
• W4296468339 creator A5005119777 @default.
• W4296468339 creator A5007606413 @default.
• W4296468339 creator A5009905725 @default.
• W4296468339 creator A5017405089 @default.
• W4296468339 creator A5028533298 @default.
• W4296468339 creator A5029787002 @default.
• W4296468339 creator A5032083634 @default.
• W4296468339 creator A5032568030 @default.
• W4296468339 creator A5058364259 @default.
• W4296468339 creator A5066416400 @default.
• W4296468339 creator A5066582496 @default.
• W4296468339 creator A5069322918 @default.
• W4296468339 date "2022-10-01" @default.
• W4296468339 modified "2023-09-30" @default.
• W4296468339 title "TCL-276 Outcome of NK/T-Cell Lymphoma – Retrospective Analysis from a Tertiary Care Cancer Center" @default.
• W4296468339 doi "https://doi.org/10.1016/s2152-2650(22)01574-9" @default.
• W4296468339 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36164125" @default.
• W4296468339 hasPublicationYear "2022" @default.
• W4296468339 type Work @default.
• W4296468339 citedByCount "0" @default.
• W4296468339 crossrefType "journal-article" @default.
• W4296468339 hasAuthorship W4296468339A5001774710 @default.
• W4296468339 hasAuthorship W4296468339A5005119777 @default.
• W4296468339 hasAuthorship W4296468339A5007606413 @default.
• W4296468339 hasAuthorship W4296468339A5009905725 @default.
• W4296468339 hasAuthorship W4296468339A5017405089 @default.
• W4296468339 hasAuthorship W4296468339A5028533298 @default.
• W4296468339 hasAuthorship W4296468339A5029787002 @default.
• W4296468339 hasAuthorship W4296468339A5032083634 @default.
• W4296468339 hasAuthorship W4296468339A5032568030 @default.
• W4296468339 hasAuthorship W4296468339A5058364259 @default.
• W4296468339 hasAuthorship W4296468339A5066416400 @default.
• W4296468339 hasAuthorship W4296468339A5066582496 @default.
• W4296468339 hasAuthorship W4296468339A5069322918 @default.
• W4296468339 hasConcept C121608353 @default.
• W4296468339 hasConcept C126322002 @default.
• W4296468339 hasConcept C143998085 @default.
• W4296468339 hasConcept C146357865 @default.
• W4296468339 hasConcept C151730666 @default.
• W4296468339 hasConcept C167135981 @default.
• W4296468339 hasConcept C2777589544 @default.
• W4296468339 hasConcept C2777872185 @default.
• W4296468339 hasConcept C2779338263 @default.
• W4296468339 hasConcept C71924100 @default.
• W4296468339 hasConcept C86803240 @default.
• W4296468339 hasConcept C90924648 @default.
• W4296468339 hasConceptScore W4296468339C121608353 @default.
• W4296468339 hasConceptScore W4296468339C126322002 @default.
• W4296468339 hasConceptScore W4296468339C143998085 @default.
• W4296468339 hasConceptScore W4296468339C146357865 @default.
• W4296468339 hasConceptScore W4296468339C151730666 @default.
• W4296468339 hasConceptScore W4296468339C167135981 @default.
• W4296468339 hasConceptScore W4296468339C2777589544 @default.
• W4296468339 hasConceptScore W4296468339C2777872185 @default.
• W4296468339 hasConceptScore W4296468339C2779338263 @default.
• W4296468339 hasConceptScore W4296468339C71924100 @default.
• W4296468339 hasConceptScore W4296468339C86803240 @default.
• W4296468339 hasConceptScore W4296468339C90924648 @default.
• W4296468339 hasLocation W42964683391 @default.
• W4296468339 hasLocation W42964683392 @default.
• W4296468339 hasOpenAccess W4296468339 @default.
• W4296468339 hasPrimaryLocation W42964683391 @default.
• W4296468339 hasRelatedWork W170895960 @default.
• W4296468339 hasRelatedWork W1968380476 @default.
• W4296468339 hasRelatedWork W2110877204 @default.
• W4296468339 hasRelatedWork W2205257049 @default.
• W4296468339 hasRelatedWork W2410620015 @default.
• W4296468339 hasRelatedWork W2412306442 @default.
• W4296468339 hasRelatedWork W2896563835 @default.
• W4296468339 hasRelatedWork W3027476803 @default.
• W4296468339 hasRelatedWork W3131095990 @default.
• W4296468339 hasRelatedWork W4360845853 @default.
• W4296468339 hasVolume "22" @default.
• W4296468339 isParatext "false" @default.
• W4296468339 isRetracted "false" @default.
• W4296468339 workType "article" @default.